Skip to content

Ovid Therapeutics Inc.

OVID· NasdaqCore metricsCIK 1636651

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -8.63%
Market cap
$479.38M
188.73M shares
Filings
537
$0.00
Q3 2026+1,181.3% FY25 yoy
-$20.78M
Q3 2026N/M FY25 yoy
-$22.36M
Q3 2026N/M FY25 yoy
-$38.33M
FY 2025derivedN/M FY25 yoy
-$0.20
Q3 2024N/M FY23 yoy
$13.81M
Q3 2026−50.0% FY25 yoy
$479.38M
—
330.4×
2.4×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$2.54+88.15%+$1.19past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$7.25MFY 2025
$208.38M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$7,252,000reported
FY 20242024-12-31$566,000reported
FY 20232023-12-31$392,000reported
FY 20222022-12-31$1,502,748reported
FY 20212021-12-31$208,382,779reported
FY 20202020-12-31$12,617,221reported

Segments

Products
Revenue by Products, FY2021 to FY2025FY2021License and other revenue · FY2021 · $12.38MLicense revenue - related party · FY2021 · $196.00MFY2022License and other revenue · FY2022 · $1.50MFY2024Royalty, License and Termination Agreement · FY2024 · $223.50MFY2025Royalty, License and Termination Agreement · FY2025 · $230.70M
LineFY2025ShareChange
Royalty, License and Termination Agreement$230.70M3181%+3.2%
License and other revenue———
License revenue - related party———
Total$7.25M

From the 10-K filed Mar 18, 2026OVID

Pharmaceutical preparations

Ovid Therapeutics Inc. is the 181st largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Ovid Therapeutics Inc. · CIK 1636651 · Engraved from SEC EDGAR